- Home
- SNGX vs SQFT Comparison
SNGX vs SQFT Comparison
Compare SNGX & SQFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- SQFT
- Stock Information
- Founded
- SNGX 1987
- SQFT 1999
- Country
- SNGX United States
- SQFT United States
- Employees
- SNGX N/A
- SQFT N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- SQFT Real Estate Investment Trusts
- Sector
- SNGX Health Care
- SQFT Real Estate
- Exchange
- SNGX Nasdaq
- SQFT Nasdaq
- Market Cap
- SNGX 9.6M
- SQFT 9.5M
- IPO Year
- SNGX 1987
- SQFT 2020
- Fundamental
- Price
- SNGX $3.51
- SQFT $0.62
- Analyst Decision
- SNGX
- SQFT
- Analyst Count
- SNGX 0
- SQFT 0
- Target Price
- SNGX N/A
- SQFT N/A
- AVG Volume (30 Days)
- SNGX 56.4K
- SQFT 38.8K
- Earning Date
- SNGX 11-08-2024
- SQFT 11-26-2024
- Dividend Yield
- SNGX N/A
- SQFT 14.86%
- EPS Growth
- SNGX N/A
- SQFT N/A
- EPS
- SNGX N/A
- SQFT N/A
- Revenue
- SNGX $364,183.00
- SQFT $18,346,853.00
- Revenue This Year
- SNGX N/A
- SQFT N/A
- Revenue Next Year
- SNGX $76.64
- SQFT N/A
- P/E Ratio
- SNGX N/A
- SQFT N/A
- Revenue Growth
- SNGX N/A
- SQFT 4.63
- 52 Week Low
- SNGX $1.83
- SQFT $0.54
- 52 Week High
- SNGX $32.00
- SQFT $1.45
- Technical
- Relative Strength Index (RSI)
- SNGX 49.14
- SQFT 37.21
- Support Level
- SNGX $3.50
- SQFT $0.68
- Resistance Level
- SNGX $3.74
- SQFT $0.73
- Average True Range (ATR)
- SNGX 0.20
- SQFT 0.05
- MACD
- SNGX 0.01
- SQFT -0.01
- Stochastic Oscillator
- SNGX 47.37
- SQFT 5.33
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.